Natalia Kozmina - ConvaTec Group Ex Officer
| CNVVF Stock | USD 2.95 0.10 3.51% |
Insider
Natalia Kozmina is Ex Officer of ConvaTec Group Plc
| Phone | 44 11 8952 8100 |
| Web | https://www.convatecgroup.com |
ConvaTec Group Management Efficiency
The company has return on total asset (ROA) of 0.0354 % which means that it generated a profit of $0.0354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0486 %, meaning that it generated $0.0486 on every $100 dollars invested by stockholders. ConvaTec Group's management efficiency ratios could be used to measure how well ConvaTec Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | INSIDER Age | ||
| Rachel Vaknin | Microbot Medical | 45 | |
| MScEE MBA | GlucoTrack | 70 | |
| Erez BenZvi | GlucoTrack | 46 | |
| Pr DSc | Microbot Medical | 72 | |
| Barry Berler | Sharps Technology | 70 | |
| Andrew CPA | Sharps Technology | 68 | |
| Steven MD | Sharps Technology | 62 | |
| Esq CPA | GlucoTrack | 59 | |
| Eyal MD | Microbot Medical | 59 | |
| Alan Blackman | Sharps Technology | 75 | |
| Robert Hayes | Sharps Technology | 57 | |
| David BA | GlucoTrack | 59 | |
Management Performance
| Return On Equity | 0.0486 | |||
| Return On Asset | 0.0354 |
ConvaTec Group Plc Leadership Team
Elected by the shareholders, the ConvaTec Group's board of directors comprises two types of representatives: ConvaTec Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ConvaTec. The board's role is to monitor ConvaTec Group's management team and ensure that shareholders' interests are well served. ConvaTec Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ConvaTec Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frank Schulkes, CFO - Designate | ||
| Karim Bitar, CEO Director | ||
| Supratim Bose, Executive Vice President and President APAC | ||
| Natalia Kozmina, Ex Officer | ||
| Mark Reynolds, Director Relations | ||
| Jonathan Mason, Group Director | ||
| Donal Balfe, Executive Vice President - Global Operations | ||
| Divakar Ramakrishnan, Ex Officer | ||
| Kate Postans, VP Communications | ||
| MSc Biotechnology, Pres Care | ||
| Christian Hoengaard, VP USA |
ConvaTec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is ConvaTec Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0486 | |||
| Return On Asset | 0.0354 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 6.84 B | |||
| Shares Outstanding | 2.04 B | |||
| Shares Owned By Insiders | 19.77 % | |||
| Shares Owned By Institutions | 60.64 % | |||
| Price To Earning | 47.32 X | |||
| Price To Book | 3.51 X |
Currently Active Assets on Macroaxis
Other Information on Investing in ConvaTec Pink Sheet
ConvaTec Group financial ratios help investors to determine whether ConvaTec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.